Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.

https://doi.org/10.1182/hematology.2019000033

Published: 2019

Journal Articles

Sequencing of therapies in relapsed follicular lymphoma

Loretta J. Nastoupil, Christopher R. Flowers, John P. Leonard

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 189–193.

https://doi.org/10.1182/asheducation-2018.1.189

Published: 2018

Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.

https://doi.org/10.1182/asheducation-2018.1.185

Published: 2018

Journal Articles

Novel immunotherapy approaches to follicular lymphoma

Christopher R. Flowers, John P. Leonard, Loretta J. Nastoupil

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 194–199.

https://doi.org/10.1182/asheducation-2018.1.194

Published: 2018

Journal Articles

Follicular lymphoma: are we ready for a risk-adapted approach?

Brad S. Kahl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 358–364.

https://doi.org/10.1182/asheducation-2017.1.358

Published: 2017

Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.

https://doi.org/10.1182/asheducation-2016.1.269

Published: 2016

Journal Articles

Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum

John T. Sandlund, Mike G. Martin

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 589–597.

https://doi.org/10.1182/asheducation-2016.1.589

Published: 2016

Journal Articles

Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?

Nathan Fowler

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 277–283.

https://doi.org/10.1182/asheducation-2016.1.277

Published: 2016

Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.

https://doi.org/10.1182/asheducation-2016.1.284

Published: 2016

Journal Articles

Treatment of patients with transformed lymphoma

Silvia Montoto

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 625–630.

https://doi.org/10.1182/asheducation-2015.1.625

Published: 2015

Journal Articles

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from the microscope

Nancy Lee Harris

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 158–162.

https://doi.org/10.1182/asheducation-2014.1.158

Published: 2014

Journal Articles

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from gene expression profiling

Lisa M. Rimsza, Melba C. Jaramillo

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 163–168.

https://doi.org/10.1182/asheducation-2014.1.163

Published: 2014

Journal Articles

Therapeutic targeting of microenvironment in follicular lymphoma

Grzegorz S. Nowakowski, Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 169–173.

https://doi.org/10.1182/asheducation-2014.1.169

Published: 2014

Journal Articles

Dissecting follicular lymphoma: high versus low risk

Sonali M. Smith

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 561–567.

https://doi.org/10.1182/asheducation-2013.1.561

Published: 2013

Journal Articles

Is there a role for “watch and wait” in follicular lymphoma in the rituximab era?

Brad Kahl

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 433–438.

https://doi.org/10.1182/asheducation.V2012.1.433.3798541

Published: 2012

Journal Articles

Changing role of stem cell transplantation in follicular lymphoma

Ginna G. Laport

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 417–425.

https://doi.org/10.1182/asheducation.V2012.1.417.3798521

Published: 2012

Journal Articles

Are you sure this is Waldenström macroglobulinemia?

Irene M. Ghobrial

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 586–594.

https://doi.org/10.1182/asheducation.V2012.1.586.3798562

Published: 2012

Journal Articles

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Adam Bagg

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 330–335.

https://doi.org/10.1182/asheducation-2011.1.330

Published: 2011

Journal Articles

Novel Agents for Follicular Lymphoma

John P. Leonard, Peter Martin

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 259–264.

https://doi.org/10.1182/asheducation-2010.1.259

Published: 2010

Journal Articles

Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy

Koen van Besien

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 610–618.

https://doi.org/10.1182/asheducation-2009.1.610

Published: 2009

NARROW

Where does transplant fit in the age of targeted therapies?

Sequencing of therapies in relapsed follicular lymphoma

Where to start? Upfront therapy for follicular lymphoma in 2018

Novel immunotherapy approaches to follicular lymphoma

Follicular lymphoma: are we ready for a risk-adapted approach?

Prognostic factors in follicular lymphoma: new tools to personalize risk

Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum

Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?

Novel agents in follicular lymphoma: choosing the best target

Treatment of patients with transformed lymphoma

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from the microscope

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from gene expression profiling

Therapeutic targeting of microenvironment in follicular lymphoma

Dissecting follicular lymphoma: high versus low risk

Is there a role for “watch and wait” in follicular lymphoma in the rituximab era?

Changing role of stem cell transplantation in follicular lymphoma

Are you sure this is Waldenström macroglobulinemia?

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Novel Agents for Follicular Lymphoma

Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only